Quantification and Explanation of the Variability of First-Dose Amikacin Concentrations in Critically Ill Patients Admitted to the Emergency Department: A Population Pharmacokinetic Analysis
ConclusionThe IIV of amikacin pharmacokinetics in ED patients is large. Higher doses may be considered in patients with low serum sodium levels, low total protein levels, or a high fluid balance.Trial RegistrationClinicalTrials.gov ID: NCT02365272.
Source: European Journal of Drug Metabolism and Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research
More News: Chronic Kidney Disease | Drugs & Pharmacology | Emergency Medicine | Epidemiology | Intensive Care | Septic Shock | Sodium | Study | Urology & Nephrology